FDA grants breakthrough designation to PathAI for pathology solution

The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology Workflow

PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...

Lumea and Voicebrook Announce Strategic Partnership to Advance Digital Pathology Workflows

Voicebrook integration into Lumea's pathology software enables practical, voice-enabled workflows across the modern ...

Acupath Laboratories, Inc. Partners with Azer Scientific to Install the First AzerView Digital Pathology Scanner in the United States

"Our focus has always been on advancing pathology through meaningful innovation," Brian Kunkel, Acupath Laboratories, "Being part of the first Vieworks scanner installation in the U.S. underscores our ...
MobiHealthNews

Roche expands digital pathology open environment to improve workflows

Pharmaceutical company Roche announced the expansion of its digital pathology open environment by integrating more than 20 advanced artificial intelligence algorithms from eight new collaborators. The ...
Seeking Alpha

Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity

Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration Collaboration combines best of clinical workflow leadership with ...
News Medical

Ligolab and Pathpresenter announce strategic partnership to deliver seamless digital pathology workflows

LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader ...
Business Wire

Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics

PORTSMOUTH, N.H. & KALAMAZOO, Mich.--(BUSINESS WIRE)--Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and ...